Dr. Reddy's Laboratories Ltd. ADR buy Barclays PLC
Start price
29.01.24
/
50%
€64.00
Target price
29.01.25
€73.92
Performance (%)
14.75%
Price
03.09.24
€73.00
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC currently has a performance of 14.75%. Dividends of €0.44 are taken into consideration when calculating the performance. This prediction currently runs until 29.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Dr. Reddy's Laboratories Ltd. ADR | -2.013% | -2.013% |
iShares Core DAX® | -1.215% | 4.788% |
iShares Nasdaq 100 | -1.911% | 1.109% |
iShares Nikkei 225® | -3.171% | 5.626% |
iShares S&P 500 | -1.029% | 1.792% |
Comments by Barclays_PLC for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target raised by analysts at Barclays PLC from $75.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for RDY provided by MarketBeat
Stopped prediction by Barclays_PLC for Dr. Reddy's Laboratories Ltd. ADR
Dr. Reddy's Laboratories Ltd. ADR
Start price
Target price
Perf. (%)
€74.50
30.07.24
30.07.24
€80.52
30.07.25
30.07.25
-2.01%
03.09.24
03.09.24
Dr. Reddy's Laboratories Ltd. ADR
Start price
Target price
Perf. (%)
€65.00
08.05.24
08.05.24
€75.37
08.05.25
08.05.25
12.99%
03.09.24
03.09.24